Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Bolt Biotherapeutics (NASDAQ:BOLT) through any online brokerage.
Other companies in Bolt Biotherapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Bolt Biotherapeutics has a consensus price target of $28.80.
The stock price for Bolt Biotherapeutics (NASDAQ: BOLT) is $3.46 last updated September 21, 2026 at 12:33 PM EDT.
There are no upcoming dividends for Bolt Biotherapeutics.
Bolt Biotherapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Bolt Biotherapeutics.
Bolt Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.